[HTML][HTML] Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - Stem cell research, 2016 - Elsevier
The derivation of dopaminergic neurons from induced pluripotent stem cells brings new
hope for a patient-specific, stem cell-based replacement therapy to treat Parkinson's disease …

Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - 2016 - agris.fao.org
The derivation of dopaminergic neurons from induced pluripotent stem cells brings new
hope for a patient-specific, stem cell-based replacement therapy to treat Parkinson's disease …

Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - Stem cell research, 2016 - pubmed.ncbi.nlm.nih.gov
The derivation of dopaminergic neurons from induced pluripotent stem cells brings new
hope for a patient-specific, stem cell-based replacement therapy to treat Parkinson's disease …

Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease.

DA Grow, JR McCarrey, CS Navara - Stem Cell Research, 2016 - europepmc.org
The derivation of dopaminergic neurons from induced pluripotent stem cells brings new
hope for a patient-specific, stem cell-based replacement therapy to treat Parkinson's disease …

[引用][C] Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - Stem Cell Research, 2016 - cir.nii.ac.jp
Advantages of nonhuman primates as preclinical models for evaluating stem cell-based
therapies for Parkinson's disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - Stem Cell Research, 2016 - infona.pl
The derivation of dopaminergic neurons from induced pluripotent stem cells brings new
hope for a patient-specific, stem cell-based replacement therapy to treat Parkinson's disease …

[PDF][PDF] Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - Stem Cell Research, 2016 - core.ac.uk
Advantages of nonhuman primates as preclinical models for evaluating stem cell-based
therapies for Parkinson's disease Page 1 Review Advantages of nonhuman primates as …

advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for parkinson's disease

DA Grow, JR McCarrey, CS Navara - journal of energy chemistry, 2016 - scimatic.org
The derivation of dopaminergic neurons from induced pluripotent stem cells brings new
hope for a patient-specific, stem cell-based replacement therapy to treat Parkinson's disease …

Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - Stem Cell Research, 2016 - scholars.uthscsa.edu
The derivation of dopaminergic neurons from induced pluripotent stem cells brings new
hope for a patient-specific, stem cell-based replacement therapy to treat Parkinson's disease …

[PDF][PDF] Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease

DA Grow, JR McCarrey, CS Navara - Stem Cell Research, 2016 - cyberleninka.org
Advantages of nonhuman primates as preclinical models for evaluating stem cell-based
therapies for Parkinson's disease Page 1 Review Advantages of nonhuman primates as …